Bristol-Myers Squibb Co (BMY.N) said it would buy privately held drugmaker Flexus Biosciences Inc for up to $1.25 billion to add an emerging class of cancer-fighting drugs to its pipeline.
1 min read · 23 February 2015
British holiday company Thomas Cook Group is seeking to sell its airline business as part of a cost-saving plan, the Sunday Times newspaper reported, without citing its sources.
1 min read · 23 February 2015
HKBN Ltd, Hong Kong's second-largest broadband Internet provider, will launch its IPO on Tuesday, with shareholders including CVC Capital Partners looking to raise up to $750 million, sources familiar with the IPO plans said.
2 min read · 23 February 2015
The private equity owners of Parques Reunidos have put on ice plans to sell the Spanish zoo, marine and water park operator that could have valued the business at about 2 billion euros, sources to Reuters News.
2 min read · 23 February 2015
Rupert Murdoch's Twenty-First Century Fox Inc held preliminary takeover talks with Discovery Communications Inc with a view to creating a $100 billion entertainment giant, the Australian Financial Review reported on Monday.
1 min read · 23 February 2015
Banks have lined up 375 million euros ($426.11 million) of leveraged loans to back private equity firm Mid Europa Partners' acquisition of a majority stake in Serbian Danube Foods Group, banking sources said on Friday.
1 min read · 20 February 2015
The world's biggest listed hedge fund company, Man Group, said on Friday it had agreed to buy the investment management business of NewSmith.
1 min read · 20 February 2015
Sarissa Capital Management LP kicked off a proxy battle with Ariad Pharmaceuticals Inc on Friday, demanding the retirement of Harvey Berger, the drugmaker's chief executive and principal founder, Reuters reported.
2 min read · 20 February 2015
The U.S. government filed a lawsuit on Thursday seeking to block Sysco Corp's proposed takeover of rival food distributor private equity-backed US Foods Inc, saying the $3.5 billion deal would "eliminate significant competition" in the sector.
3 min read · 20 February 2015
German drugmaker Bayer is in talks to sell its diabetes devices division but a sale is not imminent, two sources with knowledge of the matter told Reuters.
2 min read · 20 February 2015
